Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR5A | P47898 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | NOS1 | P29475 | 1/20 | 0.51 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.48 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18768852 | 0.88 | CYP1A2 (0.68) | CYP1A2CYP2D6CHRM2RAB9ADYRK1A | |
| SCHEMBL16606308 | 0.83 | CYP1A2 (0.74) | HTR5ACYP1A2CYP2D6CHRM2ALDH1A1 | |
| SCHEMBL2854484 | 0.82 | CYP1A2 (0.68) | CYP1A2CYP2D6CYP2C9CYP2C19ROCK1 | |
| SCHEMBL13355443 | 0.82 | RAB9A (0.63) | RAB9ACLK4ALDH1A1MEN1LMNA | |
| SCHEMBL18768843 | 0.82 | CYP1A2 (0.71) | CYP1A2CYP2D6CYP2C9CYP2C19ROCK1 | |
| SCHEMBL10561741 | 0.81 | CYP1A2 (0.61) | HTR5ACYP1A2CYP2D6CHRM2ALDH1A1 | |
| SCHEMBL1238008 | 0.79 | CYP1A2 (0.61) | HTR5ACYP1A2CYP2D6CHRM2NOS1 | |
| SCHEMBL16038317 | 0.78 | NOS1 (0.55) | HTR5ACYP1A2CYP2D6ROCK1CHRM2 | |
| SCHEMBL27569236 | 0.78 | CYP1A2 (0.56) | HTR5ACYP1A2CYP2D6CHRM2NOS1 | |
| SCHEMBL16606311 | 0.78 | CYP1A2 (0.63) | HTR5ACYP1A2CYP2D6CHRM2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3363288-B1 | COMPOSITION FOR DESTRUCTION OF MICROALGAE OR MOSSES | CUREARTH INC (KR) | 2022-09-07 | — | — | EP | disclosed |
| CN-108347925-B | Compositions for destroying microalgae or moss | 株式会社CUREARTH | 2021-07-16 | — | — | CN | disclosed |
| US-11044909-B2 | Composition for destruction of microalgae or sphaerocarpus | CUREARTH, INC. (KR) | 2021-06-29 | — | — | US | disclosed |
| US-11044909-B2 | Composition for destruction of microalgae or sphaerocarpus | CUREARTH, INC. (KR) | 2021-06-29 | — | — | US | disclosed |
| US-20180271091-A1 | COMPOSITION FOR DESTRUCTION OF MICROALGAE OR SPHAEROCARPUS | CUREARTH, INC. (KR) | 2018-09-27 | — | — | US | disclosed |
| EP-3363288-A1 | COMPOSITION FOR DESTRUCTION OF MICROALGAE OR SPHAEROCARPUS | Curearth, Inc. (KR) | 2018-08-22 | — | — | EP | disclosed |
| CN-108347925-A | composition for destroying microalgae or moss | 株式会社CUREARTH | 2018-07-31 | — | — | CN | disclosed |
| WO-2017065401-A1 | COMPOSITION FOR DESTRUCTION OF MICROALGAE OR SPHAEROCARPUS | 주식회사 큐얼스 | 2017-04-20 | — | — | WO | disclosed |
| EP-1451160-B1 | PYRAZOLE-AMIDES FOR USE IN THE TREATMENT OF PAIN | ICAGEN INC (US) | 2010-01-13 | — | — | EP | disclosed |
| US-20080064690-A1 | PYRAZOLE-AMIDES AND -SULFONAMIDES | ICAGEN, INC. (US) | 2008-03-13 | — | — | US | disclosed |
| US-7223782-B2 | Pyrazole-amides and -sulfonamides | ICAGEN, INC. (US) | 2007-05-29 | — | — | US | disclosed |
| US-20050049237-A1 | Pyrazole-amides and -sulfonamides | ICAGEN, INC. (US) | 2005-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064690-A1 | PYRAZOLE-AMIDES AND -SULFONAMIDES | SCN3A, TRPV3, HCN3 | HTR5A 1438/4885CYP1A2 1874/4885CYP2D6 2653/4885 |
| US-20050049237-A1 | Pyrazole-amides and -sulfonamides | SCN3A, TRPV3, HCN3 | HTR5A 1438/4885CYP1A2 1874/4885CYP2D6 2653/4885 |
| US-20180271091-A1 | COMPOSITION FOR DESTRUCTION OF MICROALGAE OR SPHAEROCARPUS | TK1, TRHDE, TK2 | HTR5A 4306/4885CYP1A2 4399/4885CYP2D6 4332/4885 |
| US-11044909-B2 | Composition for destruction of microalgae or sphaerocarpus | TK1, TRHDE, TK2 | HTR5A 4306/4885CYP1A2 4399/4885CYP2D6 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.